4.7 Article

The possibility of healing alveolar bone defects with simvastatin thermosensitive gel: in vitro/in vivo evaluation

Journal

DRUG DESIGN DEVELOPMENT AND THERAPY
Volume 12, Issue -, Pages 1997-2003

Publisher

DOVE MEDICAL PRESS LTD
DOI: 10.2147/DDDT.S163986

Keywords

SVT; in situ gel; thermogelling; gelation; in vitro release; alveolar hone defect

Funding

  1. National Natural Science Foundation of China [81670956]
  2. State Key Program [14JC1490600]
  3. Shanghai Cooperative International Project of Shanghai Committee of Science and Technology, China [16520710400]

Ask authors/readers for more resources

Background: In this study, simvastatin (SVT) in situ gels were successfully produced by our group. Methods: The preparations were characterized in the following aspects: in vitro gelation, drug release, stability and pharmacodynamics. Results: In this study, drug content of prepared gels was found to be in the range between 89 and 92%. The p11 value was in the range between 6.5 and 7.0. The gelation temperature of the prepared thermogelling solutions was 37 degrees C. In vitro release showed that the release of SVT from in situ gels was slow with burst effects at an early stage. Researches indicated that intraorally slow release SVT in situ gels could effectively promote bone regeneration repair of alveolar bone defect. Conclusion: This drug delivery system could prove to be a novel form able to prolong the residence time and to control the release of drug when administered into the oral cavity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available